Resveratrol prevents NAFLD in offspring by reducing hepatic steatosis, improving metabolic signaling, and modulating RAS components including ↑ ACE2, ↓ ACE1/AT1R. This evidence concerns the gene AGTR1 and metabolic dysfunction-associated steatotic liver disease.